1 / 7

Daily Equity Reports 07 Dec 2018

CapitalStars Award Winning,SEBI registered investment advisory company.We provide intraday &amp; positional services in equity,derivative ,commodity &amp; currency.<br>http://www.capitalstars.com/<br><br><br>

PeehuSharma
Download Presentation

Daily Equity Reports 07 Dec 2018

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 07TH DECEMBER 2018 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! 35312.13 INDIAN EQUITY BENCHMARK :- Benchmark indices remained under pressure throughout the session with Nifty 10601.15 ended just above 10,600 level, while Sensex lost 570 points.The ASIAN MARKET Sensex was down 572.28 points at 35,312.13, while Nifty was CLOSE PREVIOUS down 181.70 points at 10,601.20. About 745 shares have NIKKEI 21501.62 advanced, 1778 shares declined, and 150 shares are 26156.38 unchanged. Maruti Suzuki, Tata Motors, Yes Bank, Reliance 2101.31 Industries and Adani Ports are the major losers on the Sensex. GLOBAL FACE SECTORIAL INDICES CLOSE CHANGE (%) ! 10805.85 -1.67 Asian Market - Asian markets finished sharply lower today with shares in Hong Kong leading the region. The Hang Seng is down 2.47% while Japan's Nikkei 225 is off 1.91% and China's Shanghai Composite is lower by 1.68%. -1.62 -1.82 ! -1.66 U.S. Market – Dow set to fall by over 400 points at the open as market sell-off continues. .BANK NIFTY 26198.30 -1.21 ! European markets - European markets are sharply lower today with shares in London off the most. The FTSE 100 is down 2.36% while CLOSE CHANGE (%) Germany's DAX is off 2.30% and France's CAC 40 is lower by 2.14%. 1.11 JSWSTEEL 306 0.54 350 0.19 POWERGRID 0.03 TOP LOSERS CLOSE CHANGE (%) IBULHSGFIN 730 -5.97 MARUTI -4.67 -4.43 695 -4.38 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NIFTY SPOT MARKET MOVERS UPSIDE TREND STRATEGY SCRIPT CLOSE (%) 1.90 BEARISH SIEMENS 1.57 P R1 R2 10771 RESISTANCE R1-10770 R2-10930 R3 10905 10369 10503 10552 10637 10686 1.21 BAJAJ HOLD SUPPORT S1-10550 S2-10360 0.82 CLOSE (%) -5.87 750 AUROPHARMA -5.63 IBULHSGFIN -5.10 -4.74 NET (CR.) TREND BULLISH 5062.16 S3 S2 S1 26183 P R1 R2 R3 DII 2303.99 25818 26078 26338 26443 SUPPORT S1-26180 S2-25820 RESISTANCE NSE TOTALS BANK NIFTY ADVANCE 4 BANK NIFTY 1 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report MARKET TALKS ! Aurobindo to face lawsuit in US for !Power Grid wins bid for UP transmission line project Irbesartan contamination As per news sources, a lawsuit has been filed in Federal Court of Florida against Aurobindo Pharma for the contamination of its Irbesartan APIs, used in the treatment of high blood pressure.The class action lawsuit also named US pharma company ScieGen Pharmaceuticals, distributor Westminster Pharmaceuticals and the US retail supply chain giant Walmart.Earlier this year, human carcinogenic impurities were found in the APIs supplied by a Chinese company Zhejiang Huahai Pharmaceuticals. Zhejiang Huahai was manufacturing Sartan range of products which is used in the treatment of high blood pressure. Zhejiang Huahai then recalled the Sartan products in many countries. Zhejiang Huahai is currently facing several lawsuits in the USA. Shares of Power Grid Corporation of India gained in the morning session today after it bagged a project to set up a transmission system for evacuating electricity from the 1,320MW Jawaharpur thermal power project and construct a substation in Uttar Pradesh.“Power Grid has been declared as the successful bidder under Tariff based competitive bidding to establish the transmission system for evacuation of power from 2 x 660MW Jawaharpur Thermal Power Project and construction of 400kV substation at Firozabad along with associated Transmission Lines' on build-own-operate-maintain (BOOM) basis,” the company said in a filing to the exchanges after-market hours on Wednesday. ! Infosys inaugurates Hartford Technology and Innovation Hub Infosys, a global leader in next-generation digital services and consulting, inaugurated its Technology and Innovation Hub in Hartford. Infosys also announced that it has hired more than 7,000 American workers in the last 18 months as part of its ongoing commitment to accelerate the pace of digital innovation for American enterprises. ! Sagar Cements board approves investments in Satguru, Jajpur Cements The board of Sagar Cements, at its meeting on Wednesday, has approved investments in two companies, namely Satguru Cements and Jajpur Cements. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Intraday stock tips Financial advisory company Share market company Stock Tips * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

  7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

More Related